Literature DB >> 18434559

Evaluation of eight anti-rubella virus immunoglobulin g immunoassays that report results in international units per milliliter.

Wayne Dimech1, Lena Panagiotopoulos, Barbara Francis, Nicholas Laven, Joan Marler, David Dickeson, Tony Panayotou, Kim Wilson, Robyn Wootten, Elizabeth M Dax.   

Abstract

An evaluation of anti-rubella virus immunoglobulin G (IgG) immunoassays that report in international units per milliliter (IU/ml) was performed to determine their analytical performance and the degree of correlation of the test results. A total of 321 samples were characterized based on results from a hemagglutination inhibition assay. The 48 negative and 273 positive samples were used to determine the sensitivity and specificity of the assays. When equivocal results were interpreted as reactive, the sensitivity of the immunoassays ranged from 98.9 to 99.9% and the specificity ranged from 77.1 to 95.8%. All assays had positive and negative delta values of less than 2. A significant difference between the mean results of all assays was demonstrated by analysis of variance. However, post hoc analysis showed there was good correlation in the mean results expressed in IU/ml between some of the assays. Our results show the level of standardization between anti-rubella virus IgG immunoassays reporting results expressed as IU/ml has improved since a previous study in 1992, but further improvement is required.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18434559      PMCID: PMC2446858          DOI: 10.1128/JCM.00231-08

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  31 in total

1.  Automated rubella antibody screening:a cautionary tale.

Authors:  S O'Shea; H Dunn; S Palmer; J E Banatvala; J M Best
Journal:  J Med Microbiol       Date:  1999-11       Impact factor: 2.472

2.  Antenatal screening for hepatitis B and antibodies to Toxoplasma gondii and rubella virus: evaluation of two commercial immunoassay systems.

Authors:  R J Diepersloot; H Dunnewold-Hoekstra; J Kruit-Den Hollander; F Vlaspolder
Journal:  Clin Diagn Lab Immunol       Date:  2001-07

Review 3.  Interpretation of rubella serology in pregnancy--pitfalls and problems.

Authors:  Jennifer M Best; Siobhan O'Shea; Graham Tipples; Nicholas Davies; Saleh M Al-Khusaiby; Amanda Krause; Louise M Hesketh; Li Jin; Gisela Enders
Journal:  BMJ       Date:  2002-07-20

4.  The impact of rubella immunization on the serological status of women of childbearing age: a retrospective longitudinal study in Melbourne, Australia.

Authors:  Barbara H Francis; Adrian K Thomas; Catherine A McCarty
Journal:  Am J Public Health       Date:  2003-08       Impact factor: 9.308

5.  The ADVIA Centaur immunoassay system--designed for infectious disease testing.

Authors:  David Okrongly
Journal:  J Clin Virol       Date:  2004-04       Impact factor: 3.168

6.  An update on laboratory productivity with infectious disease assays on the Bayer ADVIA Centaur Immunoassay System.

Authors:  Francesco Dati
Journal:  Clin Lab       Date:  2004       Impact factor: 1.138

7.  A modified haemagglutination inhibition test for rubella antibodies, using standardized, freeze-dried reagents. Report of a comparative multi-centre trial.

Authors:  B van Weemen; J Kacaki
Journal:  J Hyg (Lond)       Date:  1976-08

Review 8.  Rubella eradication.

Authors:  S A Plotkin
Journal:  Vaccine       Date:  2001-05-14       Impact factor: 3.641

Review 9.  Rubella and congenital rubella syndrome: global update.

Authors:  Susan E Robertson; David A Featherstone; Marta Gacic-Dobo; Bradley S Hersh
Journal:  Rev Panam Salud Publica       Date:  2003-11

10.  European performance evaluations of the ADVIA Centaur infectious disease assays: requirements for performance evaluation according to the European directive on in vitro diagnostics.

Authors:  Francesco Dati; Gérard Denoyel; Josef van Helden
Journal:  J Clin Virol       Date:  2004-04       Impact factor: 3.168

View more
  15 in total

1.  Bicentric evaluation of six anti-toxoplasma immunoglobulin G (IgG) automated immunoassays and comparison to the Toxo II IgG Western blot.

Authors:  Arnaud Maudry; Gautier Chene; Rémi Chatelain; Hugues Patural; Bahrie Bellete; Bernard Tisseur; Jamal Hafid; Hélène Raberin; Sophie Beretta; Roger Tran Manh Sung; Georges Belot; Pierre Flori
Journal:  Clin Vaccine Immunol       Date:  2009-07-08

2.  Performance characteristics of current-generation Immulite 2000 TORCH Assays.

Authors:  A R Centonze; E Tonolli; R Fontana
Journal:  Clin Vaccine Immunol       Date:  2012-11-21

3.  Investigation into low-level anti-rubella virus IgG results reported by commercial immunoassays.

Authors:  Wayne Dimech; Nilukshi Arachchi; Jingjing Cai; Terri Sahin; Kim Wilson
Journal:  Clin Vaccine Immunol       Date:  2012-12-19

4.  Performance of the Elecsys Rubella IgG assay in the diagnostic laboratory setting for assessment of immune status.

Authors:  Martin Enders; Uwe Bartelt; Frank Knotek; Kristina Bunn; Sirpa Strobel; Klaus Dietz; Gisela Enders
Journal:  Clin Vaccine Immunol       Date:  2013-01-23

5.  Assessing Immunity to Rubella Virus: a Plea for Standardization of IgG (Immuno)assays.

Authors:  Elise Bouthry; Milena Furione; Daniela Huzly; Adaeze Ogee-Nwankwo; LiJuan Hao; Adebola Adebayo; Joseph Icenogle; Antonella Sarasini; Maria Grazia Revello; Liliane Grangeot-Keros; Christelle Vauloup-Fellous
Journal:  J Clin Microbiol       Date:  2016-05-04       Impact factor: 5.948

6.  High-throughput assay optimization and statistical interpolation of rubella-specific neutralizing antibody titers.

Authors:  Nathaniel D Lambert; V Shane Pankratz; Beth R Larrabee; Adaeze Ogee-Nwankwo; Min-hsin Chen; Joseph P Icenogle; Gregory A Poland
Journal:  Clin Vaccine Immunol       Date:  2014-01-03

7.  Rubella antibodies in Australian immunoglobulin products.

Authors:  Megan K Young; Joseph Bertolini; Pushpa Kotharu; Darryl Maher; Allan W Cripps
Journal:  Hum Vaccin Immunother       Date:  2017-06-12       Impact factor: 3.452

Review 8.  Standardization of Assays That Detect Anti-Rubella Virus IgG Antibodies.

Authors:  Wayne Dimech; Liliane Grangeot-Keros; Christelle Vauloup-Fellous
Journal:  Clin Microbiol Rev       Date:  2016-01       Impact factor: 26.132

9.  [Seroprevalence of rubella in Colombia: a birth-year cohort analysis].

Authors:  Doracelly Hincapie-Palacio; Viviana Lenis Ballesteros; Martha Ospina Ospina; Olga Lucía Pérez Toro; Francisco J Díaz
Journal:  Rev Saude Publica       Date:  2013-12       Impact factor: 2.106

10.  Performance of the Abbott SARS-CoV-2 IgG II Quantitative Antibody Assay Including the New Variants of Concern, VOC 202012/V1 (United Kingdom) and VOC 202012/V2 (South Africa), and First Steps towards Global Harmonization of COVID-19 Antibody Methods.

Authors:  Emma English; Laura E Cook; Isabelle Piec; Samir Dervisevic; William D Fraser; W Garry John
Journal:  J Clin Microbiol       Date:  2021-08-18       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.